Your session is about to expire
← Back to Search
Hair regrowth by SCE for Alopecia Areata
Study Summary
This trial will explore the use of stem cell therapy in combination with oral minoxidil to treat alopecia areata, a common autoimmune disease that results in loss of body hair.
- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are actively engaged in this research?
"Indeed, the information on clinicaltrials.gov confirms that this scientific endeavour is still in its active recruitment phase. The study was first announced on September 20th 2022 and recently updated November 10th of the same year. Researchers are actively searching for 20 participants from a total of 3 trial centres."
What can be gleaned from previous research on the pairing of Stem Cell Educator therapy and minoxidil?
"Initially researched at Wake Forest Baptist Health Department of Dermatology, the combination of minoxidil and Stem Cell Educator therapy has been tested across 28 distinct clinical trials as of 2021. Currently, 5 additional studies are recruiting participants; many in Hackensack, Connecticut."
What risks are associated with using Stem Cell Educator therapy alongside minoxidil for medical treatment?
"The safety of the combination therapy consisting of Stem Cell Educator and minoxidil is rated at a 2, as there are some clinical studies that provide evidence for its security but none attesting to its efficacy."
Is this investigation currently open to new participants?
"The medical trial is still on the lookout for volunteers, as indicated by its most recent update occurring on November 10th 2022. The original posting of this study was made on September 20th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Throne Biotechnologies: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger